title: Adenocarcinoma of the ampulla of Vater: does the histopathologic type matter?
authors.forename: Sousana
authors.initials: S
authors.lastname: Amptoulach
authors.forename: Axel
authors.initials: A
authors.lastname: Josefsson
authors.forename: Nikolaos
authors.initials: N
authors.lastname: Kavantzas
authors.forename: Evangelos
authors.initials: E
authors.lastname: Kalaitzakis
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology*; D014670:Ampulla of Vater / Q000473:pathology*; D000971:Antineoplastic Combined Chemotherapy Protocols; D000071616:CDX2 Transcription Factor; D002272:Carcinoembryonic Antigen / Q000032:analysis; D003138:Common Bile Duct Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology*; D018398:Homeodomain Proteins / Q000032:analysis; D006801:Humans; D007150:Immunohistochemistry; D053554:Keratin-20 / Q000032:analysis; D053552:Keratin-7 / Q000032:analysis; D008297:Male; D008875:Middle Aged
chemical_list: D000071616:CDX2 Transcription Factor; C491270:CDX2 protein, human; D002272:Carcinoembryonic Antigen; D018398:Homeodomain Proteins; D053554:Keratin-20; D053552:Keratin-7